Skip to main content
OSR Holdings, Inc. logo

OSR Holdings, Inc. — Investor Relations & Filings

Ticker · OSRH ISIN · US68840D1028 US Professional, scientific and technical activities
Open in API
Filings indexed 204 across all filing types
Latest filing 2024-09-16 Regulatory Filings
Country US United States of America
Listing US OSRH

About OSR Holdings, Inc.

https://osr-holdings.com/

OSR Holdings, Inc. is a healthcare holding company that operates using a hub-and-spoke model to manage a diverse portfolio of subsidiary companies. The company's vision is to accelerate healthcare innovation to improve health and wellness outcomes. It actively evaluates and pursues merger and acquisition opportunities that advance innovative healthcare, either by addressing unmet patient needs or by lowering patient costs and burden. The firm's development activities are focused on a portfolio of therapies and healthcare solutions, including oral immunotherapies for cancer treatment, design-augmented biologics, therapeutic antibodies, and engineered proteins.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content specifically mentions a deposit of $50,000 into a trust account related to an extension of the deadline for consummating a business combination. There are no financial statements or detailed financial data presented, nor is this a full annual or quarterly report. The document is short (3097 characters) and serves as a regulatory announcement of a specific event. This fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories such as earnings releases, annual reports, or capital updates.
2024-09-16 English
8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 20, 2024, by Bellevue Life Sciences Acquisition Corp. It details a notice of delisting due to failure to meet Nasdaq's minimum public holders requirement and the company's intention to request a hearing to avoid suspension or delisting. The content focuses on regulatory compliance and listing status rather than financial results, management changes, or other report types. The key phrase 'Notice of Delisting' and the detailed explanation about Nasdaq's delisting process clearly indicate this is a Delisting Announcement. The document length (6998 characters) and detailed content confirm it is the announcement itself, not a brief notice or a report publication announcement. Therefore, the appropriate classification is Delisting Announcement (DLST).
2024-08-22 English
10-Q
Interim / Quarterly Report Q2 2024
2024-08-19 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes a deposit of $50,000 into a trust account related to an extension of the deadline for consummating a business combination. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is short (3027 characters) and serves as a regulatory announcement of an event rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2024-08-16 English
NT 10-Q
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 Notification of Late Filing submitted to the SEC by Bellevue Life Sciences Acquisition Corp. It specifically states that the company is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, within the prescribed time period and requests an extension. The document contains no actual financial statements or substantive financial data but explains the delay and expected filing date. This is a regulatory notification about a late filing rather than the actual quarterly report (Form 10-Q) itself. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document and does not contain the report itself.
2024-08-15 English
SC 13G/A
Major Shareholding Notification
2024-08-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.